Article
Inhibition of canonical NF-κB nuclear localization by (-)-DHMEQ via impairment of DNA binding.
Oncology research - 1 Jan 2015
Horie Kana, Ma Jun, Umezawa Kazuo
Abstract excerpt
We previously discovered (-)-DHMEQ as a selective inhibitor of NF-κB, and it was shown to suppress many cancer and inflammation models in animals. (-)-DHMEQ directly binds to NF-κB components to inhibit DNA binding, and moreover, it often inhibits nuclear translocation of NF-κB. The mechanism of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
